Lajer M - Search Results

1

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P. Jorsal A, et al. Among authors: lajer m. Kidney Int. 2008 Sep;74(5):649-54. doi: 10.1038/ki.2008.201. Epub 2008 May 21. Kidney Int. 2008. PMID: 18496510 Free article.

2

Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.

Lajer M, Tarnow L, Jorsal A, Parving HH. Lajer M, et al. Nephrol Dial Transplant. 2007 Nov;22(11):3235-9. doi: 10.1093/ndt/gfm360. Epub 2007 Jun 13. Nephrol Dial Transplant. 2007. PMID: 17567649

3

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P. Lajer M, et al. Diabetes Care. 2008 Apr;31(4):747-52. doi: 10.2337/dc07-1762. Epub 2007 Dec 27. Diabetes Care. 2008. PMID: 18162497

4

The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.

Möllsten A, Lajer M, Jorsal A, Tarnow L. Möllsten A, et al. Among authors: lajer m. Mol Genet Metab. 2009 May;97(1):80-4. doi: 10.1016/j.ymgme.2009.01.013. Epub 2009 Feb 3. Mol Genet Metab. 2009. PMID: 19246226

5

Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P. Nielsen SE, et al. Among authors: lajer m. Diabetes Care. 2009 Sep;32(9):1684-8. doi: 10.2337/dc09-0429. Epub 2009 Jun 5. Diabetes Care. 2009. PMID: 19502542 Free PMC article.

6

Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy.

Overgaard AJ, Hansen HG, Lajer M, Pedersen L, Tarnow L, Rossing P, McGuire JN, Pociot F. Overgaard AJ, et al. Among authors: lajer m. Proteome Sci. 2010 Feb 3;8:4. doi: 10.1186/1477-5956-8-4. Proteome Sci. 2010. PMID: 20205888 Free PMC article.

7

Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.

Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Lajer M, et al. Diabetes Care. 2010 Jul;33(7):1567-72. doi: 10.2337/dc09-2174. Epub 2010 Mar 31. Diabetes Care. 2010. PMID: 20357380 Free PMC article.

8

Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.

Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L. Lajer M, et al. Platelets. 2010;21(7):525-32. doi: 10.3109/09537104.2010.500422. Platelets. 2010. PMID: 20701458 Free article.

9

Osteoprotegerin and mortality in type 2 diabetic patients.

Reinhard H, Lajer M, Gall MA, Tarnow L, Parving HH, Rasmussen LM, Rossing P. Reinhard H, et al. Among authors: lajer m. Diabetes Care. 2010 Dec;33(12):2561-6. doi: 10.2337/dc10-0858. Epub 2010 Oct 7. Diabetes Care. 2010. PMID: 20929997 Free PMC article.

10

Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.

Hansen HG, Overgaard J, Lajer M, Hubalek F, Højrup P, Pedersen L, Tarnow L, Rossing P, Pociot F, McGuire JN. Hansen HG, et al. Among authors: lajer m. Proteomics Clin Appl. 2010 Sep;4(8-9):697-705. doi: 10.1002/prca.200900169. Proteomics Clin Appl. 2010. PMID: 21137087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters